Lymphovascular invasion (LVI) is a significant predictor for recurrence in patients with early stage endometrial endometrioid adenocarcinoma (EEA)

被引：0
|
作者：
Nofech-Mozes, S. [1 ]
Ghorah, Z. [1 ]
Ismiil, N. [1 ]
Ackerman, I. [1 ]
Thomas, G. [1 ]
Covens, A. [1 ]
Khalifa, M. A. [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
LABORATORY INVESTIGATION | 2007年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
953
引用
收藏
页码：208A / 209A
页数：2
相关论文
共 50 条
  • [31] FACTORS ASSOCIATED WITH RECURRENCE AND SURVIVAL IN PATIENTS WITH CURATIVELY RESECTED STAGE IA ADENOCARCINOMA OF THE LUNG: LYMPHOVASCULAR INVASION CAN PREDICT RECURRENCE
    Harada, Masahiko
    Hato, Tai
    Horio, Hirotoshi
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1323 - S1324
  • [32] Early-stage endometrial cancer, CTNNB1 mutations, and the relationship between lymphovascular space invasion and recurrence
    Imboden, Sara
    Tapia, Coya
    Scheiwiller, Nadja
    Kocbek, Vida
    Altermatt, Hans J.
    Janzen, Jan
    Mueller, Michael D.
    McKinnon, Brett
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2020, 99 (02) : 196 - 203
  • [33] Endometrioid Endometrial RNA Index Predicts Recurrence in Stage I Patients
    Nief, Corrine A.
    Hammer, Phoebe M.
    Wang, Aihui
    Charu, Vivek
    Tanweer, Amina
    Litkouhi, Babak
    Kidd, Elizabeth
    Gentles, Andrew J.
    Howitt, Brooke E.
    CLINICAL CANCER RESEARCH, 2024, 30 (13) : 2801 - 2811
  • [34] Lymphovascular Space Invasion (LVSI) Is an Isolated Poor Prognostic Factor for Recurrence and Survival Among Women With Intermediate- to High-Risk Early-Stage Endometrioid Endometrial Cancer
    Weinberg, Lori E.
    Kunos, Charles A.
    Zanotti, Kristine M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08) : 1438 - 1445
  • [35] High TRPS1 Expression Predicts Distant Recurrence of Early-Stage Endometrial Endometrioid Adenocarcinoma (EMACA)
    Skvarca, Lauren
    Kousar, Aisha
    Rammal, Rayan
    Garrett, Alison
    McGough, Christine
    Elishaev, Esther
    Zhao, Chengquan
    Jones, Mirka
    Bhargava, Rohit
    Lesnock, Jamie
    Soong, Thing Rinda
    LABORATORY INVESTIGATION, 2023, 103 (03) : S984 - S986
  • [36] The Presence of Extensive Lymphovascular Invasion (LVI) is Associated with Higher Risk of Recurrence in Curatively Treated Breast Cancer Patients
    Koleoso, O. A.
    Toumbacaris, N.
    Zhang, Z.
    Braunstein, L. Z.
    El -Tamer, M.
    Moo, T. A.
    Morrow, M.
    Brogi, E.
    Xu, A. J.
    Powell, S. N.
    Khan, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S135 - S136
  • [37] Recurrence patterns and prognostic factors in lymphovascular space invasion-positive endometrioid endometrial cancer surgically confined to the uterus
    Sahin, Hanifi
    Meydanli, Mehmet Mutlu
    Sari, Mustafa Erkan
    Kocaman, Eda
    Cuylan, Zeliha Firat
    Yalcin, Ibrahim
    Coban, Gonca
    Ozen, Ozlem
    Sirvan, Levent
    Gungor, Tayfun
    Ayhan, Ali
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2019, 58 (01): : 82 - 89
  • [38] Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma
    Cun, Han T.
    Bernard, Laurence
    Lande, Karin Teien
    Lawson, Barrett C.
    Nesbakken, Anne-Jorunn
    Davidson, Ben
    Lindemann, Kristina
    Fellman, Bryan
    Sorlie, Therese
    Soliman, Pamela T.
    Eriksson, Ane Gerda Zahl
    GYNECOLOGIC ONCOLOGY, 2024, 189 : 138 - 145
  • [39] Adjuvant Chemotherapy after Liver Transplantation for Hepatocellular Carcinoma (HCC) with Lymphovascular Invasion (LVI) Reduces the Risk of Early Recurrence
    Uchida, K.
    Levi, D. M.
    Feun, L.
    Dohi, T.
    Hibi, T.
    Mosna, L.
    Fan, J.
    Tekin, A.
    Selvaggi, G.
    Maki, E.
    Weppler, D.
    Garcia, M. T.
    Nishida, S.
    Andreas, T. G.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S85 - S85
  • [40] Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma
    Huvila, Jutta
    Talve, Lauri
    Carpen, Olli
    Edqvist, Per-Henrik
    Ponten, Fredrik
    Grenman, Seija
    Auranen, Annika
    GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 463 - 469
12345